ASX:MDR

MedAdvisor (MDR) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free MDR Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: 719,064 shs
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get MedAdvisor alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About MedAdvisor Stock (ASX:MDR)

MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MDR Stock News Headlines

April 10, 2024 | finance.yahoo.com

Shareholders in MedAdvisor (ASX:MDR) are in the red if they invested five years ago

April 8, 2024 | finanznachrichten.de

ThreatLocker Inc.: ThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the World

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

April 8, 2024 | finance.yahoo.com

ThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the World

March 29, 2024 | finance.yahoo.com

4 Day Virtual Medical Device Software Compliance Course: Complying with the EU MDR, EU IVDR & FDA Regulations

March 21, 2024 | markets.businessinsider.com

EQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply

March 12, 2024 | finance.yahoo.com

ESET Webinar Outlines How to Outsmart Cybercrime with MDR

March 12, 2024 | finance.yahoo.com

Medical Device Software Course: Complying with the EU MDR, EU IVDR & FDA Regulations - 4 Day Online Event, July 22-25, 2024

April 18, 2024 | Gold Safe Exchange (Ad)

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

March 11, 2024 | finance.yahoo.com

ColdZyme® certified under the new EU medical device regulation (MDR)

March 11, 2024 | finance.yahoo.com

PulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary Interventions

March 11, 2024 | finanznachrichten.de

Enzymatica AB: ColdZyme® certified under the new EU medical device regulation (MDR)

February 29, 2024 | finance.yahoo.com

Managed Detection and Response (MDR) Market Worth $9.5 billion by 2028, Growing At a CAGR of 23.3% Report by MarketsandMarkets™

February 27, 2024 | finance.yahoo.com

BEN and MedAdvisor Solutions Team Up to Bring Conversational AI to Patients Through Pharmacies

February 27, 2024 | finance.yahoo.com

ThreatHunter.ai Unveils Special Offer for Carbon Black MDR Customers Seeking Swift and Secure Migration

February 8, 2024 | finance.yahoo.com

CSOFT Health Sciences Releases MDR White Paper to Support EU Medical Device Compliance

February 8, 2024 | finance.yahoo.com

ZOLL One of the First to Receive Approval for AEDs Under the EU Medical Device Regulation (MDR) Certification

February 5, 2024 | msn.com

High risk devices can be exempted from mandatory trials under EU MDR

January 24, 2024 | msn.com

MDR Commissioner says tax revenues continue to show growth

January 22, 2024 | msn.com

1MED prepares to unveil EU MDR compliance software

January 11, 2024 | msn.com

How is Europe’s MedTech industry navigating the EU MDR?

January 8, 2024 | finance.yahoo.com

Institutions profited after MedAdvisor Limited's (ASX:MDR) market cap rose AU$41m last week but private companies profited the most

December 21, 2023 | msn.com

JUNE Medical’s Galaxy II® self-retaining surgical retractor receives MDR certification for its high quality and safety

December 18, 2023 | tmcnet.com

"Sophos MDR is a Must" and Sophos Intercept X is "A Real Threat for Hackers," Say Sophos Customers in G2's Peer-to-Peer Winter 2024 Report

December 18, 2023 | markets.businessinsider.com

Revolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa Registration

December 4, 2023 | benzinga.com

Sophos Managed Detection and Response (MDR) Named CRN Product of the Year

November 28, 2023 | finance.yahoo.com

CHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO DRIVE ITS INTERNATONAL GROWTH

See More Headlines

Receive MDR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MedAdvisor and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: ASX:MDR
CUSIP: N/A
CIK: N/A
Web: www.medadvisor.com.au
Phone: 61 3 9095 3036
Fax: N/A
Employees: 31,900
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.02)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,030,000.00
Net Margins: -8.25%
Pretax Margin: N/A
Return on Equity: -15.21%
Return on Assets: -2.39%

Debt

Debt-to-Equity Ratio: 22.65
Current Ratio: 0.87
Quick Ratio: 0.47

Sales & Book Value

Annual Sales: $109.43 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: 7.95
Book Value: A$0.10 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 550,150,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.66

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Richard Ratliff
CEO, MD & Director
Ms. Ancila Desai B.Com.
C.A., M.B.A., CFO & Joint Company Secretary
Mr. Craig Schnuriger
Acting Chief Technology Officer
Mr. James M. Rotsart R.Ph.
Executive VP of US & Client Relations
Mr. Wayne Marinoff
President of ANZ
Ms. Anshu Raghuvanshi
Joint Company Secretary

Key Competitors

View All Competitors

Insiders

Jim Xenos
Sold 6,846,955 shares
Total: $1.23 M ($0.18/share)

This page (ASX:MDR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

MedAdvisor (MDR) Stock Price, News & Analysis

About MedAdvisor Stock (ASX:MDR)

MDR Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info